Nexium Pay-For-Delay Plaintiffs Can't Prove Conspiracy
A Massachusetts federal judge on Friday narrowed the plaintiffs' theories in a pay-for-delay trial against AstraZeneca PLC and two generic producers over the heartburn drug Nexium, ruling there wasn't enough evidence...To view the full article, register now.
Already a subscriber? Click here to view full article